US price cuts, Medicare expansion, and new oral GLP-1 approvals reshape the competitive outlook for weight-loss drugs.

"Arrival of GLP-1 weight-loss pill creates new headache for food, drink makers" was originally created and published by Just Food, a GlobalData owned brand.

U.S. regulators have approved a pill version of the weight-loss drug Wegovy, a boon for drugmaker Novo Nordisk ...

The US Food and Drug Administration today approved a pill version of the blockbuster anti-obesity drug Wegovy. Made by Novo ...

Monday’s approval gives Novo Nordisk a win against GLP-1 competitor Eli Lilly, which manufactures a weight loss injectable ...

The Wegovy pill is one of two oral GLP-1 drugs expected to hit the market in the next few months; the other, from Lilly, is called orforglipron – until it receives a brand name – and is expected to be ...

A significant breakthrough in the weight-loss medication market: the FDA has approved the first GLP-1 pill for obesity treatment. The post FDA approves Wegovy GLP-1 pill, pushing weight-loss drugs ...

Telehealth Provider Offers FDA-Approved and Compounded Weight Loss Medications in All 50 States, Subject to RegulationsSAN DIEGO, Dec. 26, 2025 (GLOBE NEWSWIRE) -- As the post-holiday period brings ...

Food makers and restaurants adjust menus and products as GLP-1 drugs drive demand for high-protein foods and smaller portions ...

The FDA has approved the first oral glucagon-like peptide-1 (GLP-1) receptor agonist for weight loss and to reduce the risk ...

People who switched to the experimental daily GLP-1 pill orforglipron were able to maintain their weight loss after stopping ...